Wayfinding Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,254
Closed -$203K 176
2026
Q1
$203K Buy
+7,254
New +$193K 0.09% 154
2025
Q2
Sell
-6,376
Closed -$161K 556
2025
Q1
$161K Sell
6,376
-1,717
-21% -$44.9K 0.07% 166
2024
Q4
$214K Buy
+8,093
New +$220K 0.11% 127
2024
Q3
Sell
-7,982
Closed -$223K 104
2024
Q2
$223K Sell
7,982
-1,977
-20% -$54.4K 0.13% 111
2024
Q1
$281K Buy
9,959
+960
+11% +$26.6K 0.16% 91
2023
Q4
$259K Sell
8,999
-430
-5% -$13K 0.18% 89
2023
Q3
$320K Buy
9,429
+469
+5% +$16.6K 0.24% 70
2023
Q2
$323K Buy
8,960
+718
+9% +$27.9K 0.22% 71
2023
Q1
$336K Buy
8,242
+734
+10% +$31.7K 0.26% 65
2022
Q4
$400K Sell
7,508
-870
-10% -$41.7K 0.32% 55
2022
Q3
$366K Buy
8,378
+584
+7% +$28.4K 0.34% 46
2022
Q2
$408K Buy
7,794
+279
+4% +$14.2K 0.36% 48
2022
Q1
$368K Buy
7,515
+7
+0.1% +$363 0.31% 53
2021
Q4
$400K Buy
+7,508
New +$372K 0.32% 55

Other funds holding PFE

Wayfinding Financial's PFE Position: Q2 2026 in Review

Wayfinding Financial sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,254 shares — an estimated $203K sold.

Wayfinding Financial first reported a position in PFE in Q4 2021 and held it in 14 quarters. The position peaked at $408K in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wayfinding Financial reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Wayfinding Financial sold 7,254 Pfizer shares in Q2 2026, an estimated $203K.
  • Wayfinding Financial first reported a position in Pfizer in Q4 2021 and held it in 14 quarters.
  • Wayfinding Financial's Pfizer position peaked at $408K in Q2 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wayfinding Financial's 13F filing for Q2 2026, filed 13 Aug 2026.